ECOVA CORPORATION

(Bioslurry Reactor)

TECHNOLOGY DESCRIPTION:

The ECOVA Corporation (ECOVA) slurry-phase bioremediation (bioslurry) technology aerobically biodegrades creosote-contaminated materials. The technology uses batch and continuous flow bioreactors to process polynuclear aromatic hydrocarbon (PAH)-contaminated soils, sediments, and sludges. The bioreactors are supplemented with oxygen, nutrients, and a specific inoculum of enriched indigenous microorganisms to enhance the degradation process.

Because site-specific environments influence biological treatment, all chemical, physical, and microbial factors are designed into the treatment process. The ultimate goal is to convert organic wastes into relatively harmless by-products of microbial metabolism, such as carbon dioxide, water, and inorganic salts. Biological reaction rates are accelerated in a slurry system because of the increased contact efficiency between contaminants and microorganisms. The photograph below shows the bioslurry reactor.

Bioslurry Reactor

WASTE APPLICABILITY:

The bioslurry reactor is designed to treat highly contaminated creosote wastes. It can also treat other concentrated contaminants that can be aerobically biodegraded, such as petroleum wastes. The bioslurry reactor system must be engineered to maintain parameters such as pH, temperature, and dissolved oxygen within ranges conducive to the desired microbial activity.

STATUS:

This technology was accepted into the SITE Demonstration Program in spring 1991. From May through September 1991, EPA conducted a SITE demonstration using six bioslurry reactors at EPA's Test and Evaluation Facility in Cincinnati, Ohio.

ECOVA conducted bench- and pilot-scale studies to evaluate bioremediation of PAHs in creosote-contaminated soil from the Burlington Northern Superfund site in Brainerd, Minnesota. Bench-scale studies were conducted before pilot-scale evaluations to determine optimal treatment protocols. EIMCO Biolift slurry reactors were used for the pilot-scale processing. Data from the optimized pilot-scale program were used to establish treatment standards for K001 wastes as part of EPA's Best Demonstrated Available Technology program.

This technology is no longer available through ECOVA. However, the technology is being implemented by Walsh Environmental Scientists & Engineers. For further information on the technology, contact either the EPA Project Manager or the technology developer contact.

DEMONSTRATION RESULTS:

Results from the SITE demonstration indicated that slurry-phase biological treatment significantly improved biodegradation rates of carcinogenic 4- to 6-ring PAHs. The pilot-scale bioslurry reactor reduced 82 ± 15 percent of the total soil-bound PAHs in the first week. After 14 days, total PAHs had been biodegraded by 96 ± 2 percent. An overall reduction of 97 ± 2 percent was observed over a 12-week treatment period, indicating that almost all biodegradation occurred within the first 2 weeks of treatment. Carcinogenic PAHs were biodegraded by 90 ± 3.2 percent to 501 ± 103 milligrams per kilogram (mg/kg) from levels of 5,081 ± 1,530 mg/kg.

FOR FURTHER INFORMATION:

EPA PROJECT MANAGER:
Ronald Lewis
U.S. EPA
National Risk Management Research Laboratory
26 West Martin Luther King Drive
Cincinnati, OH 45268
513-569-7856
Fax: 513-569-7105

TECHNOLOGY DEVELOPER CONTACT:
William Mahaffey
Walsh Environmental Scientists & Engineers
4888 Pearl E. Circle, Suite 108
Boulder, CO 80301-2475
303-670-2875
303-443-3282
Fax: 303-443-0367